[1] D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol,2006,44(1):217-231. [2] Cardoso AC,Carvalho-Filho RJ, Marcellin P. Transient elastography in chronic viral hepatitis:a critical appraisal. Gut,2011,60(6):759-764. [3] Ferraioli G,Tinelli C,Dal-Bello B,et al. Performance of liver stiffness measurements by transient elastography in chronic hepatitis. World J Gastroenterol,2013,19(1):49-56. [4] Stebbing J,Farouk L,Panos G,et al. A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol,2010,44(3):214-219. [5] 袁平戈.瞬时弹性成像技术在肝病诊断中的应用进展.实用肝脏病杂志,2016, 19(1): 4-7. [6] Anca T,Catalin S,Camelia C,et al. Increased liver stiffness in extra-hepatic cholestasis caused by choledocholithiasis. Hepat Mon,2011,2011(5):372-375. [7] Castéra L,Foucher J,Bernard PH,et al. Pitfalls of liver stiffness measurement:a 5-year prospective study of 13,369 examinations. Hepatology,2010,51(3):828-835. [8] Weiskirchen R,Tacke F. Combining Golgi protein 73 with liver stiffness measurements:a proof-of-concept for non-invasive fibrosis assessment in antiviral-naive HBV patients. Liver Int,2017,37(11):1605. [9] Iftikhar R,Kladney RD,Havlioglu N,et al. Disease-and cell-specific expression of Golgi protein 73 in human liver disease. AM J Gastroenterol,2004,99:1087-1095. [10] 中华医学会肝病学分会及感染病学分会.慢性乙型肝炎防治指南(2015更新版).实用肝脏病杂志,2016,19(3):Ⅴ-ⅩⅩⅢ. [11] 中华医学会肝病学分会及感染病学分会.丙型肝炎防治指南(2015年更新版).实用肝脏病杂志,2015,29(12):1961-1979. [12] 中国肝炎防治基金会,中华医学会感染病学分会,中华医学会肝病学分会和中国研究型医院学会肝病专业委员会.瞬时弹性成像技术诊断肝纤维化专家共识(2018年更新版).中华肝脏病杂志,2019,27(3):182-191. [13] Bedossa P,Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology,1996,24(2):289-293. [14] 中华医学会肝病学分会、消化病学分会及感染病学分会.肝纤维化诊断及治疗共识(2019年).实用肝脏病杂志,2019,22(6):793-803. [15] Campana L,Iredale JP. Regression of liver fibrosis. Semin Liver Dis,2017,37(1):1-10. [16] Marcellin P,Gane E,Buti M,et al.Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B:a 5-year open-label follow-up study. Lancet,2013,381(9865):468-475. [17] Cadranel JF,Rufat P,Degos F. Practices of liver biopsy in France:results of a prospective nationwide survey. Hepatology,2000,32:477-481. [18] Tseng PL,Wang JH,Hung CH,et al. Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations. Kaohsiung J Med Sci,2013,29(7):385-395. [19] Lim JK,Flamm SL,Singh S,et al. American gastroenterological association institute guideline on the role of elastography in the evaluation of liver fibrosis. Gastroenterology,2017,152(6):1536-1543. [20] Bellan M,Castello LM,Pirisi M. Candidate biomarkers of liver fibrosis:a concise,pathophysiology-oriented review. J Clin Transl Hepatol,2018,6(3):317-325. [21] Kladney RD,Bulla GA,Guo L,et al. GP73,a novel Golgi-localized protein upregulated by viral infection. Gene,2000,249(1):53-65. [22] Mao Y,Yang H,Xu H,et al. Golgi protein 73 is a valuable serum marker for hepatocelluar carcinoma. Gut,2010,59(12):1687-1693. [23] Yao MJ,Wang LJ,You H,et al. Serum gp73 combined AST and GGT reflects moderate to severe liver inflammation in chronic hepatitis B. Clin Chim Acta,2019,493:92-97. [24] Cao Z,Li Z,Wang H,et al. Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection. Liver Int,2017,37(11):1612. |